291 related articles for article (PubMed ID: 27804888)
1. Recent Advances in the Synthesis and Anticancer Activity of Some Molecules Other Than Nitrogen Containing Heterocyclic Moeities.
Akhtar MJ; Yar MS; Khan AA; Ali Z; Haider MR
Mini Rev Med Chem; 2017; 17(17):1602-1632. PubMed ID: 27804888
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene.
Alblewi FF; Okasha RM; Hritani ZM; Mohamed HM; El-Nassag MAA; Halawa AH; Mora A; Fouda AM; Assiri MA; Al-Dies AM; Afifi TH; El-Agrody AM
Bioorg Chem; 2019 Jun; 87():560-571. PubMed ID: 30928878
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities.
Akhtar J; Khan AA; Ali Z; Haider R; Shahar Yar M
Eur J Med Chem; 2017 Jan; 125():143-189. PubMed ID: 27662031
[TBL] [Abstract][Full Text] [Related]
4. Anticancer platinum(II) complexes bearing N-heterocycle rings.
Facchetti G; Rimoldi I
Bioorg Med Chem Lett; 2019 Jun; 29(11):1257-1263. PubMed ID: 30935797
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of Novel Nitrogen Heterocycle-Containing Ursolic Acid Analogs as Antitumor Agents.
Wang W; Lei L; Liu Z; Wang H; Meng Q
Molecules; 2019 Mar; 24(5):. PubMed ID: 30832266
[TBL] [Abstract][Full Text] [Related]
6. New synthetic chitosan hybrids bearing some heterocyclic moieties with potential activity as anticancer and apoptosis inducers.
El-Naggar MM; Haneen DSA; Mehany ABM; Khalil MT
Int J Biol Macromol; 2020 May; 150():1323-1330. PubMed ID: 31743719
[TBL] [Abstract][Full Text] [Related]
7. Heterocyclic Scaffolds: Centrality in Anticancer Drug Development.
Ali I; Lone MN; Al-Othman ZA; Al-Warthan A; Sanagi MM
Curr Drug Targets; 2015; 16(7):711-34. PubMed ID: 25751009
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, Anticancer Evaluation and Docking Studies of Novel Heterocyclic Derivatives Obtained via Reactions Involving Curcumin.
Borik RM; Fawzy NM; Abu-Bakr SM; Aly MS
Molecules; 2018 Jun; 23(6):. PubMed ID: 29890691
[TBL] [Abstract][Full Text] [Related]
9. Anticancer properties of an important drug lead podophyllotoxin can be efficiently mimicked by diverse heterocyclic scaffolds accessible via one-step synthesis.
Magedov IV; Frolova L; Manpadi M; Bhoga Ud; Tang H; Evdokimov NM; George O; Georgiou KH; Renner S; Getlik M; Kinnibrugh TL; Fernandes MA; Van slambrouck S; Steelant WF; Shuster CB; Rogelj S; van Otterlo WA; Kornienko A
J Med Chem; 2011 Jun; 54(12):4234-46. PubMed ID: 21615090
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of dimeric furanoid macroheterocycles: discovery of new anticancer agents.
Nicolaou KC; Nilewski C; Hale CR; Ahles CF; Chiu CA; Ebner C; ElMarrouni A; Yang L; Stiles K; Nagrath D
J Am Chem Soc; 2015 Apr; 137(14):4766-70. PubMed ID: 25827338
[TBL] [Abstract][Full Text] [Related]
11. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.
Khwaza V; Mlala S; Oyedeji OO; Aderibigbe BA
Molecules; 2021 Apr; 26(9):. PubMed ID: 33918996
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and anti-proliferative activity of heterocyclic hypervalent organoantimony compounds.
Chen Y; Yu K; Tan NY; Qiu RH; Liu W; Luo NL; Tong L; Au CT; Luo ZQ; Yin SF
Eur J Med Chem; 2014 May; 79():391-8. PubMed ID: 24747750
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer activity of new class of bisphosphonates/phosphanamidates.
Kiran YB; Devendranath Reddy C; Gunasekar D; Suresh Reddy C; Leon A; Barbosa LC
Eur J Med Chem; 2008 Apr; 43(4):885-92. PubMed ID: 17640773
[TBL] [Abstract][Full Text] [Related]
15. Fluoroalkane thioheterocyclic derivatives and their antitumor activity.
Li G; Sun Q; Wang D; Xu Y; Zhuang J; Zhang Q; Sun D
Eur J Med Chem; 2015 Mar; 93():423-30. PubMed ID: 25728023
[TBL] [Abstract][Full Text] [Related]
16. Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity.
Alcolea V; Plano D; Encío I; Palop JA; Sharma AK; Sanmartín C
Eur J Med Chem; 2016 Nov; 123():407-418. PubMed ID: 27487570
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel heterocyclic oleanolic acid derivatives with improved antiproliferative activity in solid tumor cells.
Leal AS; Wang R; Salvador JA; Jing Y
Org Biomol Chem; 2013 Feb; 11(10):1726-38. PubMed ID: 23381885
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Review of N-Heterocycles as Cytotoxic Agents.
Kumar D; Jain SK
Curr Med Chem; 2016; 23(38):4338-4394. PubMed ID: 27516198
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of nitrogen-containing macrocyclic bisbibenzyl derivatives as potent anticancer agents by targeting the lysosome.
Sun B; Liu J; Gao Y; Zheng HB; Li L; Hu QW; Yuan HQ; Lou HX
Eur J Med Chem; 2017 Aug; 136():603-618. PubMed ID: 28570977
[TBL] [Abstract][Full Text] [Related]
20. Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways.
Zhang L; Zhang Z; Chen F; Chen Y; Lin Y; Wang J
Eur J Med Chem; 2016 Nov; 123():226-235. PubMed ID: 27484511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
